BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15767556)

  • 1. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
    Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
    Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
    Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
    Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation of rabbit lens epithelial cells by S-phase kinase-interacting protein 2 targeting small interfering RNA.
    Su Y; Wang F; Yan Q; Teng Y; Cui H
    Mol Vis; 2010 May; 16():907-15. PubMed ID: 20508867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
    Fang L; Hu Q; Hua Z; Li S; Dong W
    Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level.
    Wang F; Qi LX; Su Y; Yan QH; Teng Y
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1475-82. PubMed ID: 19875654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma.
    Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T
    Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.
    Katagiri Y; Hozumi Y; Kondo S
    J Dermatol Sci; 2006 Jun; 42(3):215-24. PubMed ID: 16504485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.
    Zhang B; Ji LH; Liu W; Zhao G; Wu ZY
    World J Gastroenterol; 2013 Aug; 19(30):4917-24. PubMed ID: 23946596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
    Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin.
    Sun L; Cai L; Yu Y; Meng Q; Cheng X; Zhao Y; Sui G; Zhang F
    Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):999-1007. PubMed ID: 18064393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell proliferation of pterygium fibroblasts.
    Su Y; Wang F; Qi H; Zhao SG; Li X; Cui H
    Mol Vis; 2011 Jan; 17():247-56. PubMed ID: 21270971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R; Wang TT; Miller WH; White JH
    Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H; Wierenga AT; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
    Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
    J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
    Huang HC; Way TD; Lin CL; Lin JK
    Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of p27Kip1 promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin D1 and CDK4. Evidence for impaired Skp2-dependent degradation of p27 in terminal differentiation.
    Tamamori-Adachi M; Hayashida K; Nobori K; Omizu C; Yamada K; Sakamoto N; Kamura T; Fukuda K; Ogawa S; Nakayama KI; Kitajima S
    J Biol Chem; 2004 Nov; 279(48):50429-36. PubMed ID: 15371458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.